2,9-Bis(2,6-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone

Catalog No. :
ACIAUK395
CAS No. :
76372-76-4
Molecular Formula :
C40H26N2O4
Molecular Weight :
598.66

IUPAC Name:2,9-bis(2,6-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone

2,9-Bis(2,6-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$85.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,9-Bis(2,6-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone
IUPAC Name2,9-bis(2,6-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone
MDL No.MFCD00134588
Molecular FormulaC40H26N2O4
Molecular Weight598.66
SMILESO=C1N(C(C2=CC=C3C4=CC=C5C(N(C(C6=CC=C(C7=CC=C1C2=C37)C4=C65)=O)C8=C(C)C=CC=C8C)=O)=O)C9=C(C)C=CC=C9C
InChI KeyNJOMGKAERDOZHP-UHFFFAOYSA-N
Synonym76372-76-4 | 2,9-Bis(2,6-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone | 7,18-bis(2,6-dimethylphenyl)-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,1
CAS No.76372-76-4
PubChem CID4189394

Synthetic Route by SureRoute

1. ACIAUK395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHGAB425 route compound structure diagram
    ACHGAB425608-28-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIAUK395 route product structure diagram
    ACIAUK39576372-76-4
Inquiry

2. ACIAUK395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIAUK395 route product structure diagram
    ACIAUK39576372-76-4
Inquiry

Comments (0)